BTL-785-7 for Wrinkles

Phase-Based Progress Estimates
Schweiger Dermatology PC, Reseach Division, Hackensack, NJ
BTL-785-7 - Device
All Sexes
What conditions do you have?

Study Summary

This study will evaluate the clinical efficacy, safety and the performance of the BTL-785-7 applicator of the BTL-785F system for non-invasive treatment of facial wrinkles and overall improvement of facial appearance.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 5 months

5 months
Evaluation of Overall Facial Appearance According to GAIS
Evaluation of Wrinkle Severity
Histological examination
Subject Satisfaction
Therapy Comfort

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
BTL-785-7 Treatment
1 of 2
Active Control
Experimental Treatment

7 Total Participants · 2 Treatment Groups

Primary Treatment: BTL-785-7 · No Placebo Group · N/A

BTL-785-7 Treatment
Experimental Group · 1 Intervention: BTL-785-7 · Intervention Types: Device
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:
First Studied
Drug Approval Stage
How many patients have taken this drug

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 5 months
Closest Location: Schweiger Dermatology PC, Reseach Division · Hackensack, NJ
Photo of Hackensack 1Photo of Hackensack 2Photo of Hackensack 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Wrinkles
0 CompletedClinical Trials

Who is running the clinical trial?

BTL Industries Ltd.Lead Sponsor
42 Previous Clinical Trials
1,503 Total Patients Enrolled
9 Trials studying Wrinkles
276 Patients Enrolled for Wrinkles

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are willing to comply with study instructions, to return to the clinic for the required visits, to undergo punch biopsies and to have photographs of their face taken.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.